Prompted by the recent CAMEO trial publication on icatibant, we dive into angioedema with a focus on airway management.
Audio is streamed directly from the publisher (media.blubrry.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Show Notes
Take Home Points
- Airway management is paramount, expect a challenging intubation and consider controlling the airway early
- When controlling the airway, consider an awake approach and fiberoptics if available. Always be prepared for the can’t intubate, can’t oxygenate scenario with a double set up.
- If the patient has urticaria and pruritus, the process is likely histamine mediated and will respond to typical anaphylaxis treatment
- Finally, observe the patient for progression of swelling and don’t forget to stop the inciting medication
Read More
Core EM: Angioedema
EMCrit: Podcast 145 – Awake Intubation Lecture from SMACC
ERCast: Angioedema
REBEL EM: Icatibant Doesn’t Improve Outcomes in ACE-I Induced Angioedema
The SGEM: Icatibant Bites the Dust – For ACE-I Induced Angioedema
Read More